Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer
- 27 February 2015
- journal article
- Published by Springer Science and Business Media LLC in Wiener klinische Wochenschrift
- Vol. 128 (17-18), 635-640
- https://doi.org/10.1007/s00508-015-0724-8
Abstract
It was reported that hematological markers of systemic inflammatory response might be prognostic in various cancer types. We aimed to evaluate the platelet/lymphocyte ratio (PLR) as a prognostic factor and its effect on overall survival in non-small cell lung cancer (NSCLC).Keywords
This publication has 19 references indexed in Scilit:
- Neutrophil Count and the Inflammation-based Glasgow Prognostic Score Predict Survival in Patients with Advanced Gastric Cancer Receiving First-line ChemotherapyAsian Pacific Journal of Cancer Prevention, 2014
- Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinomaWorld Journal of Surgical Oncology, 2014
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Association of Nutrition Parameters Including Bioelectrical Impedance and Systemic Inflammatory Response With Quality of Life and Prognosis in Patients With Advanced Non-Small-Cell Lung Cancer: A Prospective StudyNutrition and Cancer, 2012
- Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancerBiomarkers, 2012
- Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancerNeoplasma, 2012
- Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancerClinical and Translational Oncology, 2011
- Lung CancerNew England Journal of Medicine, 2008
- Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group DataJournal of Clinical Oncology, 2005
- Involvement of platelets in tumour angiogenesis?The Lancet, 1998